Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma

Metabolic disturbance of lipids is a hallmark of nonalcoholic fatty liver disease (NAFLD). In this study, we measured the serum levels of 15 acylcarnitine species of various carbon chain lengths from 2 to 18 in 241 patients with biopsy-proven NAFLD, including 23 patients with hepatocellular carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Enooku, Kenichiro, Nakagawa, Hayato, Fujiwara, Naoto, Kondo, Mayuko, Minami, Tatsuya, Hoshida, Yujin, Shibahara, Junji, Tateishi, Ryosuke, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650415/
https://www.ncbi.nlm.nih.gov/pubmed/31337855
http://dx.doi.org/10.1038/s41598-019-47216-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650415/
https://www.ncbi.nlm.nih.gov/pubmed/31337855
http://dx.doi.org/10.1038/s41598-019-47216-2

Ejemplares similares